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1. Introduction 
Since their definition by Bangham in 1965 [l] , 
liposomes have been extensively used in model mem- 
brane systems, and more recently as carriers of drugs 
[2,4] , enzymes [5,9], antibodies [lo] and interferon 
inducers [111, either in model systems, or in vivo. 
Gregoriadis and Ryman described the fate of liposome- 
entrapped 13’ I-labelled albumin injected intravenously 
into rats [ 121, showing first that there was no signifi- 
cant leakage of the entrapped protein during the blood 
transit, and secondly that liposomes were rapidly 
concentrated in certain organs, mainly the liver. It has 
been recently demonstrated that the inoculation route 
as well as the size of liposomes can influence their 
fate in vivo [4] . It is also possible to considerably 
enhance the cellular uptake of liposomes by coating 
these with isologous heat-aggreagated IgG [9] or 
IgM [8] and even to direct liposomes more specifically 
towards certain cells with cell-specific IgG [3]. 
We thought hat this double function of liposomes, 
namely protection and transport, could be positively 
applied to increase the in vivo interferon activity. The 
efficiency of exogenous interferon as a prophylactic 
or therapeutic anti-viral and anti-tumor agent has 
been demonstrated, particularly in the mouse [13,14]. 
However, because of a rapid dilution and/or degrada- 
tion of interferon in the organism [ 15 ,161 successful 
treatments have necessitated rather large amounts of 
interferon and/or repeated inoculations. Entrapment 
of interferon in liposomes might obviate these disadvan- 
tages and render it more efficient. 
It seems now well established that mouse interferon 
is a glycoprotein with two molecular forms: form A, 
with mol. wt 38 000 and an isoelectric point of 
7.35; form B, with mol. wt 22 000 and an isoelectric 
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point of 7.15 [17,18]. Since much larger proteins 
have been entrapped in liposomes [7,8,10], the size 
of the interferon molecule was not ‘a prior’ a limiting 
factor. 
In the present report we have characterized the 
association between liposoties and interferon through 
the anti-viral state induced in Mouse L cells by the 
complex. 
2. Materials and methods 
2.1. Cells and viruses 
Mouse LOB cells, kindly provided by Dr E. de 
Maeyer (Institut du Radium, Orsay), were grown in 
monolayers in Eagle’s Minimum Essential Medium 
(MEM) supplemented with 10% calf serum. 
Cz4s3 Cells [ 191, a gift from Dr M. Tovey (Institut 
de Recherches sur le Cancer, Villejuif) were grown in 
monolayers in MEM plus non-essential mino acids, 
which noticeably reduced their doubling time. 
Newcastle Disease Virus (NDV), strain Hertfordshire, 
was grown in the allantoic cavity of 10 day-old 
embryonated chicken eggs. 
Vesicular Stomatitis Virus (VSV, serotype Indiana) 
was kindly provided by Dr A. Flamand (FacultC des 
Sciences, Orsay). 
2.2. Interferon 
Interferon (IF) was produced in C2453 cells 
according to the procedure described by Gresser et al. 
[20], except hat cells were kept in monolayers 
throughout induction. Crude mouse interferon, 
kindly supplied by Dr Desrumeaux (Lxlboratoire 
Roger Bellon), was used in some experiments. 
Crude IF was semi-purified as follows: IF was 
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acidified to pH 2.0, held at 4°C for 4 days, clarified 
by centrifugation, then exposed to a step-wise 
ammonium sulfate precipitation at pH 2.0 (30-80% 
saturation). Finally, interferon was dialysed against 
0.05 M phosphate buffer, pH 7.4, and stored at 
- 70°C. 
Interferon (free or liposome-bound) was titrated in 
L2s cells as follows: serial 2-fold dilutions in MEM + 
5% calf serum were incubated in duplicate with 
24 h-old L cell monolayers for 17 h at 37°C. Mono- 
layers were then washed with MEM, infected with 
100 plaque forming units of VSV, overlaid with 
nutrient agarose, then incubated at 37°C for 24 h in a 
humidified incubator with 5% COs . IF titers were 
expressed as the reverse of the dilution which reduced 
the number of VSV plaques by 50%. 
2.3. Protein 
Protein was quantified by the method of Lowry 
[21] ; our preparations of interferon had spec. act. 
5 X lo5 - IO6 units/mg protein. 
2.4. Liposomes 
2.4.1. Preparation 
Egg lecithin-(L+phosphatidyl-choline, Sigma), 
stearylamine ordicetyl phosphate, and cholesterol 
were used in the molar ratio 7:2: 1; 50 mg lipids in 
CHCls were added to a round-bottom flask, and using 
a rotary evaporator, auniformly thin film was formed. 
Subsequently 5 ml IF in 0.05 M phosphate buffer 
was added. From this stage, two different procedures 
were alternatively used: 
&ocedure I (Sonicated liposomes) 
Flasks were kept at 4°C for 2 h and then 
sonicated for 4 min using a 12 mm probe (Siduse 
sonicator); rather good clarification of the suspension 
was obtained. Crude suspension (0.5 ml) was layered 
onto a Sephadex G-l 50 column (1 X 20 cm) and 
eluted with 0.05 M phosphate buffer, NaC10.4 M, 
pH 7.4. Relative lipid concentration was determined 
in each 2 ml fraction of the eluate by measuring the 
apparent absorbance at 410 nm. Liposomes were 
isolated in the exclusion peak. Free IF eluted much 
later than lipid-containing fractions. 
&ocedure 2 (Unsonicated liposomes) 
The flasks were mechanically shaken for 
1.5 h at 20°C (Griffin Shaker). Under these conditions 
the lipid film was completely suspended into a milky 
suspension of large liposomes; 5ml of this crude 
suspension was centrifuged at 10’ X g for 2.5 h at 
4°C. The clear supernatant was carefully removed, 
and the pellet was resuspended into 5 ml phosphate 
buffer. 
2.4.2. Determination of liposome-bound IF activity 
IF associated with liposomes was titrated in L cells 
by the same method as free IF (see 2.2.), the anti-viral 
titer obtained is referred to as liposome-bound IF. 
2.4.3. Solubilisation by Trition X-100 
Crude liposome suspensions were incubated for 
10 min at 20°C in the presence of 1% (v/v) Triton 
X-100 (Rohm and Haas). A good clarification of the 
suspension was observed. At the end of the reaction, 
samples were diluted loo-fold in phosphate buffered 
saline plus lo/,, bovine serumalbumin (BSA) before 
titration. 
2.4.4. Treatment with trypsin 
Trypsin, 50 pg/ml (B grade, Calbiochem) was added 
to soluble or liposome-bound IF at 37”C, pH 7.6, in 
the presence of lo/00 BSA. Samples were withdrawn 
at intervals, supplemented with 50 &ml soybean 
trypsin inhibitor (Calbiochem), then diluted loo-fold 
in MEM t 5% calf serum before titration. 
3. Results 
3.1. Beliminary data 
Our anti-viral substance fulfilled all the physico- 
chemical and biological properties of interferon: non 
dialysable, not precipitable at 10’ X g for 2.5 h; 
sensitive to trypsin and resistant to pH 2.0. It was 
mouse-specific since it inhibited the growth of VSV 
and EMC virus in mouse cells, but had no effect on 
VSV growth in bovine cells or hamster cells. 
We designed acontrol experiment to ascertain 
whether the presence of liposomes influenced the 
titer of soluble interferon. Two sets of L cell mono- 
layers were incubated in parallel with interferon alone 
or with interferon plus preformed liposomes. Inter- 
feron titers were identical in both cases. 
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Table 1 
Interferon activity (% initial activity) associated with sonicated liposomes (Procedure 1) 
May 1977 
IF + lipids + sonication 
Expt. No. Control IF IF + soni- Net charge Crude Liposome- 
cation liposomes suspensiona associated IFb 
1 100 10 - 17 9.6 
2 100 17 + 30 20 
a Interferon titer of the suspension before chromatography 
b Total interferon activity (% initial activity) in liposome-containing fractions of the eluate 
Expt 1: Liposomes were made of lecithin, dicetyl-phosphate, cholesterol (-) 
Expt 2: Liposomes were made of lecithin, stearylamine, cholesterol (+) 
3.2. Determination of liposome-bound interferon 
activity 
Initially the lipids were suspended in interferon 
solutions by sonication. The resulting small liposomes 
could easily be separated from free interferon by 
column chromatography (Procedure 1). Table 1 shows 
the results of 2 experiments involving respectively 
anionic and cationic liposomes; in spite of the drastic 
inactivation of control interferon by sonication (about 
90%), it was possible to recover respectively 9.6% and 
20% of initial activity in anionic and cationic lipo- 
somes. This result was probably relevant to the greater 
uptake of cationic liposomes by the cells [7,11] . 
In a second set of experiments, sonication was 
avoided, and replaced by mechanical shaking; the 
resulting large liposome could not be passed through 
a column, and consequently were separated from free 
interferon by ultracentrifugation (Procedure 2). In 
this set of experiments (including only anionic lipo- 
somes) we tested the protective effect of BSA. We 
observe (table 1) that, in the absence of BSA, there 
was a marked inactivation of interferon, and here 
again liposomes exhibited an apparently protective 
effect (most residual activity in this case was recovered 
in the pellet after centrifugation). On the other hand, 
if BSA was effective in preventing inactivation of 
control interferon, its presence did not significantly 
increase the final yield of liposome-bound interferon. 
A possible competition between interferon and BSA 
for binding to liposomes might explain this result. As 
far as comparison between interferon titers in control 
solutions and in liposome suspensions is possible, we 
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Fig.1. Action of trypsin on liposome-associated interferon. 
IF was dialysed against 0.05 M phosphate buffer pH 7.6, 
and liposomes (anionic and cationic) were made as described, 
and sonicated for 4 min. Trypsinization was performed as 
described in Materials and methods (o-o) Control IF; 
(A---A) IF + anionic liposomes; (9-m) IF + cationic 
liposomes. 
193 
Volume 77, number 2 FEBSLETTERS 
Table 2 
Interferon activity (% initial activity) associated with non-sonicated 
liposomes (Procedure 2) 
May 1977 
IF + lipids + shaking 
Control 
IF 
IF+ 
shaking 
Crude 
suspension 
Supernatant Pellet 
(a) 100 6.0 30 1.4 18 
(b) 100 72 44 16.7 17 
(a) Average of 2 experiments - No BSA added 
(b) Average of 4 experiments - lo/,, BSA added 
In these experiments, liposomes contained dicetyl phosphate (anionic liposomes) 
recovered here again an appreciable amount of the 
initial activity in liposomal fractions (18% and 17%). 
3.3. Fraction of interferon activity resistant to trypsin 
Figure 1 shows the kinetics of hydrolysis by trypsin 
of crude liposome-interferon suspensions and of 
control interferon. We trypsinized crude suspensions 
instead of isolated liposomes to avoid potential 
problems arising from centrifugation, amely a loss 
of interferon by handling, and a loss of the smaller 
liposomes in the supernatant. 
The results clearly show that in either type of 
liposomes (anionic or cationic) there was a fraction of 
interferon which was simultaneously resistant to 
trypsin and still biologically active in cell culture. This 
fraction was 4% of the total interferon activity in 
anionic liposomes and 5% of the total in cationic ones. 
From the preceding results (tables 1 and 2) the 
trypsin-resistant fraction could therefore be estimated 
to .be 20 - 5 = 15% of initial activity. These two 
fractions will be referred to as Fraction 1 (trypsin 
sensitive) and Fraction 2 (trypsin resistant). 
All the results presented so far concern titratable 
interferon, i.e., anti-viral activity, which could be 
expressed in cell culture without disruption of the 
liposome structure. 
3.4. Action of Triton X-l 00 on liposome associated 
interferon 
Triton X-100 has been widely used to demonstrate 
the latency of various molecules in liposomes [5,7-91. 
In our system we examined the detergent-induced 
release of interferon from liposomes. The results had 
to be analysed more qualitatively than quantitatively, 
since liposome solubilisation by Triton is never com- 
plete and this detergent exerts a degrading effect upon 
control interferon solutions under the conditions 
used. Table 3 shows two different experiments which 
demonstrate, one with anionic, the other with cationic 
liposomes, the effect of Triton X-100. If we consider 
the loss of activity in control solutions (about 60%) 
it is clear that in both experiments solubilisation of 
liposomes led to the release of a masked fraction of 
interferon (Fraction 3). 
Table 3 
Action of Triton X-100 on crude suspensions of liposome-bound interferon 
Expt No. 
1 
2 
Triton concentration Control IF IF + liposomes 
(% v/v) (%) (units/ml) 
0 100 21000 
1 40 30 000 
0 100 36 000 
1 45 40 000 
Expt 1: Sonicated, anionic liposomes 
Expt 2: Non-sonicated, cationic liposomes 
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4. Lliscussion 
We have shown an association between mouse 
interferon and liposomes made of egg-lecithin, 
cholesterol and a charged lipid. Our results uggest 
the existence of three different fractions of liposome- 
associated interferon: the first fraction being titratable 
in cell culture and trypsin sensitive, amounted to 
14-16% of the initial activity (Fraction 1). Another 
fraction was also biologically active, but trypsin 
resistant, representing 4-S% of the initial activity 
(Fraction 2). A third fraction, of unknown amount, 
was latent, i.e., unable to trigger the anti-viral state 
in the cell unless it was liberated by Triton X-100 
(Fraction 3). 
Before further discussion, we should point out the 
distinction to be made between interferon activity 
(expressed in IF units/ml) and real interferon concen- 
tration (unknown). It is probable that binding of 
interferon to a liposome will modify its intrinsic 
anti-viral activity, basically because the cell recognizes 
the liposomes and treats them correspondingly and 
any bound molecules will be dependant on cell- 
liposomes interactions. An example is given by the 
work of Magee t al. [7] who found that liposome- 
entrapped horseradish peroxidase was taken up by 
HeLa cells at least 300-times as efficiently as free 
enzyme. 
Considering that 1520% of our initial activity 
was found associated with liposomes, even in condi- 
tions where most control interferon was inactivated, 
and that the major part of this activity was trypsin- 
sensitive (Fraction l), we suspect that externally- 
bound molecules acquire a higher intrinsic activity. 
This would explain the apparent ‘protective’ effect of 
liposomes against sonication or shaking (see tables 1 
and 2). This potentiating effect was more pronounced 
with cationic liposomes. 
Fraction 3 might include molecules of internal 
location. By some mechanism, perhaps endocytosis of 
liposomes and fusion with cellular liposomes, the 
most internal molecules are prevented from reaching 
their site of action. The work of Chany et al. [22] 
with Sepharose-bound interferon suggested that 
interferon can trigger the anti-viral state from outside 
the cell. 
It will be difficult to assess precisely the spread of 
interferon within the different liposomal compartments 
as long as the biological activity is the only available 
marker for this protein. Even so, our results uggest 
that liposomes might be promising tools for improving 
therapeutic action of interferon in vivo. In particular, 
we demonstrated that a fraction of interferon activity 
(Fraction 2) was simultaneously active in cell culture 
and trypsin-resistant; even if this fraction is, a priori, 
the most likely to utilize the previously mentioned 
functions of liposomes, we should not minimize the _ 
possible roles of Fraction 1 and Fraction 3. 
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